STOCK TITAN

Southern Cross: July 2027 deal deadline unless extended

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Southern Cross Acquisition I Corp. reported $613,858 in net income for the quarter ended September 30, 2026, from $801,362 of Trust Account investment income, partly offset by $187,504 of formation and operating costs.

The company completed its July 22, 2026 IPO, selling 11,500,000 units at $10.00 each for $115,000,000 in gross proceeds. It placed $115,000,000 from IPO and private-placement proceeds into the Trust Account, which held $115,801,362 at September 30. Cash outside the Trust Account was $545,039, and working capital was $520,921. The blank-check company has not selected a business-combination target.

Management determined that the required business-combination deadline raises substantial doubt about the company’s ability to continue as a going concern. The company must complete a business combination within 12 months of the IPO closing—by July 22, 2027, unless extended—or cease operations, redeem public shares and liquidate.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointManagement cited substantial doubt about continuing as a going concern, with a July 22, 2027 business-combination deadline unless extended.

Filing Explained

The rights can issue shares without payment at a completed combination, while warrants add shares only after exercise at $11.50 each.

At September 30, 2026, Southern Cross Acquisition I Corp. had selected no target and completed no business combination; it reported 11,500,000 each of its public rights and public warrants, and 239,300 each of its private rights and private warrants, outstanding.

If these instruments deliver shares, the additional shares would reduce existing holders’ percentage ownership; no shares had yet been issued through these rights or warrants at the reporting date.

Each four rights automatically entitles its holder to one ordinary share when a business combination closes, with no additional payment—even if the holder redeemed its public shares. Each whole warrant may be exercised for one ordinary share at $11.50, but only after the later of 30 days after a combination and one year after the IPO registration statement became effective.

If the company does not complete a business combination within 12 months of the IPO closing, unless extended, public rights expire worthless; the warrant terms also provide for expiration upon liquidation.

Quarterly net income $613,858 Three months ended September 30, 2026
Trust Account investment income $801,362 Three months ended September 30, 2026
Formation and operating costs $187,504 Three months ended September 30, 2026
Nine-month net income $529,835 Nine months ended September 30, 2026
Cash used in operating activities $290,649 Nine months ended September 30, 2026
Cash outside Trust Account $545,039 As of September 30, 2026
Working capital $520,921 As of September 30, 2026
Trust Account assets $115,801,362 As of September 30, 2026
substantial doubt technical
"substantial doubt about the Company’s ability to continue as a going concern"
ordinary shares subject to possible redemption financial
"ordinary shares subject to possible redemption are presented at redemption value"
deferred underwriting commission financial
"deferred underwriting commission payable upon the consummation"
Working Capital Loans financial
"availability of Working Capital Loans, if necessary"
Working capital loans are short-term loans companies use to cover everyday operational expenses—such as payroll, inventory purchases, or utility bills—when incoming cash is delayed or uneven. Investors care because frequent or growing reliance on these loans can signal ongoing cash-flow stress and higher financial risk, while occasional use can simply smooth predictable ups and downs; like a household using a short-term loan to bridge paychecks, it affects a company’s short-term stability and flexibility.
redemption value financial
"recorded at redemption value and classified as temporary equity"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much cash and how many Trust Account assets did NCO report?

As of September 30, 2026, NCO had $545,039 in cash outside the Trust Account and $115,801,362 in Trust Account assets.

When does NCO’s business-combination period end?

NCO’s 12-month business-combination period ends July 22, 2027, unless extended under its amended and restated memorandum and articles of association.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________

 

Commission File Number 001-42386

 

Southern Cross Acquisition I Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

N/A

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

1412 Broadway

21st Floor Suite 21V

New York, NY 10018

(Address of principal executive offices and zip code)

 

(646) 257-5537

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol

 

Name of each exchange on which registered

Units, consisting of one ordinary share, $0.0001 par value, one redeemable Warrant to acquire one ordinary share, and one Right to acquire one-fourth of one ordinary share

 

NCOOU

 

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

 

NCO

 

The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50

 

NCOOW

 

The Nasdaq Stock Market LLC

Rights, each whole right to acquire one-fourth of one ordinary share

 

NCOOR

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐     No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

 

 

Emerging growth company

☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒     No ☐

 

As of the date hereof, there were 14,729,300 of the registrant’s ordinary shares, par value $0.0001 per share, issued and outstanding.

 

 

 

 

Southern Cross Acquisition I Corp.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION

 

3

 

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

 

3

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

23

 

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

26

 

Item 4. CONTROLS AND PROCEDURES

 

26

 

PART II – OTHER INFORMATION

 

27

 

Item 1. LEGAL PROCEEDINGS

 

27

 

Item 1A. RISK FACTORS

 

27

 

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES

 

27

 

Item 3. DEFAULTS UPON SENIOR SECURITIES

 

27

 

Item 4. MINE SAFETY DISCLOSURES

 

27

 

Item 5. OTHER INFORMATION

 

27

 

Item 6. EXHIBITS

 

28

 

SIGNATURES

 

29

 

 

 
2

Table of Contents

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

SOUTHERN CROSS ACQUISITION I CORP.

CONDENSED BALANCE SHEETS

(UNAUDITED)

 

 

 

September 30,

2026

 

 

December 31,

2025

 

 

 

(Unaudited)

 

 

(Audited)

 

Assets

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$545,039

 

 

$346,015

 

Prepaid expenses

 

 

95,742

 

 

 

43,000

 

Total Current Assets

 

 

640,781

 

 

 

389,015

 

Non-current Assets

 

 

 

 

 

 

 

 

Deferred offering costs

 

 

-

 

 

 

100,000

 

Investments held in Trust Account

 

 

115,801,362

 

 

 

-

 

Total Assets

 

$116,442,143

 

 

$489,015

 

Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accrued expenses

 

$83,560

 

 

$-

 

Promissory note – related party

 

 

-

 

 

 

469,300

 

Other payable – related party

 

 

36,300

 

 

 

-

 

Total Current Liabilities

 

 

119,860

 

 

 

469,300

 

Deferred underwriting commission payable

 

 

1,150,000

 

 

 

-

 

Total Liabilities

 

 

1,269,860

 

 

 

469,300

 

Commitments and Contingencies (Note 6)

 

 

 

 

 

 

 

 

Ordinary shares subject to possible redemption, 11,500,000 and nil shares at redemption value of $10.07 and $10.00 per share as of September 30, 2026 and December 31, 2025, respectively

 

 

115,801,362

 

 

 

-

 

Shareholders' Equity (Deficit):

 

 

 

 

 

 

 

 

Preference shares, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding

 

 

-

 

 

 

-

 

Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 3,229,300 and 2,875,000* shares issued and outstanding (excluding 11,500,000 and nil shares subject to possible redemption) as of September 30, 2026 and December 31, 2025, respectively

 

 

324

 

 

 

288

 

Additional paid-in capital

 

 

-

 

 

 

24,712

 

Accumulated deficit

 

 

(629,403)

 

 

(5,285)

Total Shareholders' (Deficit) Equity

 

 

(629,079)

 

 

19,715

 

Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' (Deficit) Equity

 

$116,442,143

 

 

$489,015

 

 

*Give retroactive effect to the repurchase of 1,725,000 ordinary shares from Sponsor, and issuance of 2,875,000 ordinary shares to the Sponsor on April 15, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
3

Table of Contents

 

SOUTHERN CROSS ACQUISITION I CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

For the Three

Months Ended

September 30, 2026

 

 

For the Three

Months Ended

September 30, 2025

 

 

For the Nine

Months Ended

September 30, 2026

 

 

For the Period from April 15, 2025

(Inception) through

September 30, 2025

 

Formation and operating costs

 

$187,504

 

 

$1,230

 

 

$271,527

 

 

$1,230

 

Loss from operations

 

 

(187,504)

 

 

(1,230)

 

 

(271,527)

 

 

(1,230)

Other income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income earned on investments held in Trust Account

 

 

801,362

 

 

 

-

 

 

 

801,362

 

 

 

-

 

Net income (loss)

 

$613,858

 

 

$(1,230)

 

$529,835

 

 

$(1,230)

Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption

 

 

8,875,000

 

 

 

-

 

 

 

2,990,842

 

 

 

-

 

Basic and diluted net income per share, ordinary shares subject to possible redemption

 

$0.56

 

 

$-

 

 

$2.89

 

 

$-

 

Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares (1)

 

 

3,062,829

 

 

 

2,500,000

 

 

 

2,689,671

 

 

 

2,500,000

 

Basic and diluted net loss per share, non-redeemable ordinary shares

 

$(1.43)

 

$(0.00)

 

$(3.01)

 

$(0.00)

 

(1) Excludes an aggregate of up to 375,000 ordinary shares subject to forfeiture prior to the underwriters' full exercise of the over-allotment option on July 22, 2026. Gives retroactive effect to the repurchase of 1,725,000 ordinary shares from Sponsor, and issuance of 2,875,000 ordinary shares to the Sponsor on April 15, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
4

Table of Contents

 

SOUTHERN CROSS ACQUISITION I CORP.

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

(UNAUDITED)

 

 

 

For the Three and Nine Months Ended September 30, 2026

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

Additional

 

 

 

 

 

 

Shareholders'

 

 

 

Ordinary Shares

 

 

Paid-in

 

 

Subscription

 

 

Accumulated

 

 

Equity

 

 

 

Shares*

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

Deficit

 

 

(Deficit)

 

Balance as of December 31, 2025 (Audited)*

 

 

2,875,000

 

 

$288

 

 

$24,712

 

 

$-

 

 

$(5,285 )

 

$19,715

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(64,285 )

 

 

(64,285 )

Balance as of March 31, 2026 (Unaudited)

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

-

 

 

 

(69,570 )

 

 

(44,570 )

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(19,738 )

 

 

(19,738 )

Balance as of June 30, 2026 (Unaudited)

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

-

 

 

 

(89,308 )

 

 

(64,308 )

Fair value of public rights and warrants included in public units

 

 

-

 

 

 

-

 

 

 

14,048,000

 

 

 

-

 

 

 

-

 

 

 

14,048,000

 

Sale of private placement units

 

 

239,300

 

 

 

24

 

 

 

2,392,976

 

 

 

-

 

 

 

-

 

 

 

2,393,000

 

Issuance of representative shares

 

 

115,000

 

 

 

12

 

 

 

387,538

 

 

 

-

 

 

 

-

 

 

 

387,550

 

Allocated value of transaction costs to public rights and warrants

 

 

-

 

 

 

-

 

 

 

(400,271 )

 

 

-

 

 

 

-

 

 

 

(400,271 )

Share-based compensation – founder shares transferred to officers and directors

 

 

-

 

 

 

-

 

 

 

47,180

 

 

 

-

 

 

 

-

 

 

 

47,180

 

Initial accretion of carrying value to redemption value

 

 

-

 

 

 

-

 

 

 

(16,500,135 )

 

 

-

 

 

 

(352,591 )

 

 

(16,852,726 )

Subsequent accretion of carrying value to redemption value

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(801,362 )

 

 

(801,362 )

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

613,858

 

 

 

613,858

 

Balance as of September 30, 2026 (Unaudited)

 

 

3,229,300

 

 

$324

 

 

$-

 

 

$-

 

 

$(629,403 )

 

$(629,079 )

  

 

 

For the Period from April 15, 2025 (Inception) through September 30, 2025

 

 

 

 

 

Additional

 

 

 

 

 

 

Total

 

 

 

Ordinary Shares

 

 

Paid-in

 

 

Subscription

 

 

Accumulated

 

 

Shareholders'

 

 

 

Shares*

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

Deficit

 

 

Equity

 

Balance as of April 15, 2025 (Inception)

 

 

-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

 

$-

 

Founder shares issued to initial shareholder

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

(25,000 )

 

 

-

 

 

 

-

 

Balance as of June 30, 2025 (Unaudited)

 

 

2,875,000

 

 

 

288

 

 

 

24,712

 

 

 

(25,000 )

 

 

-

 

 

 

-

 

Received proceeds from subscription receivable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25,000

 

 

 

-

 

 

 

25,000

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,230 )

 

 

(1,230 )

Balance as of September 30, 2025 (Unaudited)

 

 

2,875,000

 

 

$288

 

 

$24,712

 

 

$-

 

 

$(1,230 )

 

$23,770

 

 

*Give retroactive effect to the repurchase of 1,725,000 ordinary shares from Sponsor, and issuance of 2,875,000 ordinary shares to the Sponsor on April 15, 2026.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
5

Table of Contents

 

SOUTHERN CROSS ACQUISITION I CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

For the Nine Months Ended

September 30, 2026

 

 

For the Period from

April 15, 2025

(Inception) through

September 30, 2025

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net income (loss)

 

$529,835

 

 

$(1,230 )

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

 

 

Income earned on investments held in Trust Account

 

 

(801,362 )

 

 

-

 

Share-based compensation

 

 

47,180

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses

 

 

(52,742 )

 

 

(43,000 )

Accrued expenses

 

 

(13,560 )

 

 

-

 

Net Cash Used in Operating Activities

 

 

(290,649 )

 

 

(44,230 )

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

Investment of cash in Trust Account

 

 

(115,000,000 )

 

 

-

 

Net Cash Used in Investing Activities

 

 

(115,000,000 )

 

 

-

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from sale of Units, net of underwriting discounts paid

 

 

113,850,000

 

 

 

-

 

Proceeds from sale of Private Units

 

 

2,393,000

 

 

 

-

 

Proceeds from promissory note – related party

 

 

-

 

 

 

173,000

 

Repayment of promissory note – related party

 

 

(433,000 )

 

 

-

 

Proceeds from issuance of ordinary shares to Sponsor

 

 

-

 

 

 

25,000

 

Payment of offering costs

 

 

(320,327 )

 

 

(50,000 )

Net Cash Provided by Financing Activities

 

 

115,489,673

 

 

 

148,000

 

Net Change in Cash

 

 

199,024

 

 

 

103,770

 

Cash, beginning of period

 

 

346,015

 

 

 

-

 

Cash, end of period

 

$545,039

 

 

$103,770

 

Supplemental Disclosure of Non-cash Financing Activities:

 

 

 

 

 

 

 

 

Deferred offering costs included in accrued expenses

 

$97,120

 

 

$-

 

Deferred underwriting commission payable

 

$1,150,000

 

 

$-

 

Issuance of representative shares

 

$387,550

 

 

$-

 

Reclassification of promissory note to other payable – related party

 

$36,300

 

 

$-

 

Initial accretion of carrying value to redemption value

 

$16,852,726

 

 

$-

 

Subsequent accretion of carrying value to redemption value

 

$801,362

 

 

$-

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
6

Table of Contents

 

Note 1 — ORGANIZATION, BUSINESS OPERATION AND GOING CONCERN CONSIDERATION

 

Southern Cross Acquisition I Corp. (the “Company”), formerly known as RTNVM Acquisition Corp., was incorporated on April 15, 2025, and completed a name change on August 4, 2025. The Company is a blank check company incorporated in the Cayman Islands as an exempted company with limited liability, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities (the “Business Combination”). To date, the Company has not selected any potential Business Combination target nor initiated any substantive discussions, directly or indirectly, with any such prospects. The Company has selected December 31 as its fiscal year end.

 

As of September 30, 2026, the Company had not commenced any operations. For the period from April 15, 2025, (inception) through September 30, 2026, the Company’s efforts have been limited to organizational activities as well as activities related to the Initial Public Offering and Private Placement (as defined below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and Private Placement.

 

The Company’s founders include the Company’s officers, directors and Sponsor (the “Founders”). The Company’s Sponsor is Southern Cross Acquisition I Sponsor Corp., a Cayman Islands company (the “Sponsor”).

 

On July 22, 2026, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units”), which included 1,500,000 Units issued pursuant to the underwriters’ exercise in full of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share (a “Public Share”), one right to receive one-fourth (1/4) of one ordinary share (a “Public Right”), and one redeemable warrant (a “Public Warrant”). Each four Public Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination. Each whole Public Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 239,300 units (the “Private Units”) at a price of $10.00 per Private Unit to the Sponsor in a private placement (the “Private Placement”), generating gross proceeds of $2,393,000. The Private Units are identical to the Units sold in the Initial Public Offering.

 

Transaction costs amounted to $3,204,997, consisting of $1,150,000 of underwriting commissions which was paid in cash at the closing date of the IPO, $1,150,000 of deferred underwriting commissions, $387,550 of the Representative Shares (discussed below), and $517,447 of other offering costs. At the IPO closing date, cash of $645,899 was held outside of the trust account and is available for the payment of accrued offering costs and for working capital purposes.

 

In conjunction with the IPO, the Company issued to the underwriter 115,000 ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, “Compensation – Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $387,550.

 

The Company’s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and interest income earned on the Trust Account that is released to the Company to pay taxes) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete such Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

 
7

Table of Contents

 

 

Upon the closing of the Initial Public Offering, $10.00 per Unit from the net proceeds of the initial Public Offering and the sales of the Private Units was placed into a United States-based Trust Account (“Trust Account”), maintained by Continental Stock Transfer & Trust Company, acting as trustee, and invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

 

Except with respect to interest earned on the funds held in the Trust Account that may be released to pay the Company’s tax obligations and liquidation expenses up to $100,000, the proceeds from the Initial Public Offering and the sale of the Private Units that are deposited in the Trust Account will not be released from the Trust Account until the earliest to occur of: (a) the completion of the initial Business Combination, (b) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend the Company’s memorandum and articles of association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete the Business Combination within 12 months from the closing of the Initial Public Offering or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, and (c) the redemption of the Public Shares if the Company is unable to complete the Business Combination within 12 months from the closing of the Initial Public Offering, subject to applicable law. Although the Company will seek to have all vendors, including lenders for money borrowed, prospective target businesses or other entities the Company engages execute agreements with the Company waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Company’s public shareholders, the proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public shareholders. The Public Shares subject to possible redemption were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. If the Company cannot complete a Business Combination within 12 months from the closing of the Initial Public Offering, unless the Company extends such period pursuant to its amended and restated memorandum and articles of association, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company (which interest shall be net of income taxes payable, and less up to $100,000 of interest to pay liquidation expenses) divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Public Rights or the rights included in the Private Units (the “Private Rights”). The Public Rights and Private Rights will expire worthless if the Company fails to complete a Business Combination within the 12-month time period.

 

Liquidity and Capital Resources

 

Prior to the consummation of the Initial Public Offering, the Company’s liquidity needs were satisfied through advances from the Sponsor pursuant to an unsecured promissory note. On April 7, 2026, the Company issued a promissory note to the Sponsor to evidence the loans previously provided to the Company by the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $500,000 to fund a portion of the expenses related to the Initial Public Offering. Prior to the closing of the Initial Public Offering, the Company had drawn down an aggregate of $469,300 under the promissory note. In connection with the closing of the Initial Public Offering on July 22, 2026, $433,000 of the outstanding balance under the promissory note was settled, and the remaining $36,300 was reclassified as other payable – related party as of July 22, 2026.

 

As of September 30, 2026, the Company had cash of $545,039 held outside the Trust Account and working capital of $520,921. Following the consummation of the Initial Public Offering, the Company’s liquidity needs are expected to be satisfied through the funds held outside the Trust Account and, if necessary, Working Capital Loans from the Company’s founders, officers and directors or their affiliates or designees.

 

 
8

Table of Contents

 

 

In order to fund working capital deficiencies or finance transaction costs in connection with an initial Business Combination or to extend the Company’s life, the Company’s founders, officers and directors or their affiliates or designees may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). The Working Capital Loans would be evidenced by promissory notes and would either be repaid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of such Working Capital Loans may be converted upon consummation of the initial Business Combination into working capital units (the “Working Capital Units”) at a price of $10.00 per unit. If the Company does not complete an initial Business Combination, the Working Capital Loans will not be repaid. As of September 30, 2026 and December 31, 2025, the Company had no borrowings outstanding under any Working Capital Loans.

 

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,” management believes that the funds held outside the Trust Account, together with the availability of Working Capital Loans, if necessary, will be sufficient to meet the Company’s working capital needs for at least one year from the date the unaudited condensed financial statements are issued. However, the Company is required to complete an initial Business Combination within 12 months from the closing of the Initial Public Offering, unless such period is extended pursuant to the Company’s amended and restated memorandum and articles of association. If the Company is unable to complete an initial Business Combination within the required period, the Company will cease all operations except for the purpose of winding up, redeem the Public Shares and thereafter liquidate and dissolve, subject to its obligations under applicable law. The mandatory liquidation date is less than one year after the date these unaudited condensed financial statements are issued. Accordingly, management has determined that the mandatory liquidation provision raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date the unaudited condensed financial statements are issued. The unaudited condensed financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

 

Note 2 — SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The interim financial information provided is unaudited but includes all adjustments which management considers necessary for the fair presentation of the results for the period. Operating results for the interim period ended September 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart The Company’s Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

 
9

Table of Contents

 

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

Cash consists of cash on hand and deposits placed with banks or other financial institutions and have original maturities of less than three months.

 

Investments Held in Trust Account

 

The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government treasury bills with a maturity of 185 days or less, and cash. The Company’s investments held in the Trust Account are classified as trading securities and are presented on the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income earned on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

 

As of September 30, 2026, the assets held in the Trust Account amounted to $115,801,362, consisting of $115,800,482 invested in U.S. Treasury bills maturing on January 21, 2027 and $880 held in cash. As of December 31, 2025, there were no assets held in the Trust Account. For the three and nine months ended September 30, 2026, the Company earned $801,362 on investments held in the Trust Account, which was reinvested in the Trust Account and is therefore presented as an adjustment to reconcile net income to net cash used in operating activities in the unaudited condensed statements of cash flows.

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2026 and December 31, 2025.

 

Offering Costs

 

The Company complies with the requirements of ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are directly related to the Initial Public Offering. The Company allocated the proceeds from the Initial Public Offering among the ordinary shares, Public Rights and Public Warrants included in the Units using the residual method, whereby the proceeds were first allocated to the Public Rights and Public Warrants based on their respective fair values, with the residual proceeds allocated to the ordinary shares. Offering costs were allocated to the underlying instruments based on the same allocation methodology. Offering costs allocated to the Public Shares were charged to temporary equity, while offering costs allocated to the Public Rights, Public Warrants and Private Placement Units were charged to shareholders’ deficit, as the Public Rights, Public Warrants and the securities underlying the Private Placement Units were classified as equity. Upon the closing of the Initial Public Offering on July 22, 2026, offering costs totaled $3,204,997, of which $2,804,726 was charged to temporary equity and $400,271 was charged to shareholders’ deficit. As of September 30, 2026 and December 31, 2025, the Company had deferred offering costs of $0 and $100,000, respectively.

 

 
10

Table of Contents

 

 

Share-Based Compensation

 

The Company accounts for share-based compensation in accordance with ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). Share-based awards issued or transferred to employees, directors and nonemployees in exchange for services provided to the Company are measured based on the fair value of the awards on the grant date.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the unaudited condensed financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company has identified Cayman Islands as its only “major” tax jurisdiction, as defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s unaudited condensed financial statements.

 

The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws.

 

The Company’s tax provision was deemed to be de minimis for the period presented. The Company is considered to be an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.

 

Fair Value of Financial Instruments Measurements

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying unaudited condensed balance sheets, primarily due to their short-term nature.

The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows:

 

 

·

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

 

 

 

 

·

Level 2 - Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

 

 

 

 

·

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

 
11

Table of Contents

 

 

At September 30, 2026, the assets held in the Trust Account were held in U.S. Treasury bills and cash. All of the Company’s investments held in the Trust Account are classified as trading securities. At December 31, 2025, there were no assets held in the Trust Account.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

 

 

September 30, 2026

 

 

 

 

 

(Unaudited)

 

 

December 31, 2025

 

 

 

Level

 

 

Fair value

 

 

Level

 

 

Fair value

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Investments held in Trust Account

 

 

1

 

 

$115,801,362

 

 

 

—

 

 

$—

 

 

Warrant and Rights Instruments

 

The Company accounts for the Public Warrants, Private Warrants, Public Rights and Private Rights issued in connection with the Initial Public Offering and the sale of Private Placement Units in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Based on its evaluation of the terms of the warrants and rights, the Company determined that such instruments qualify for equity classification. Accordingly, the warrants and rights are recorded in shareholders’ equity and are not subsequently remeasured.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of one cash account in a financial institution located in the United States. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks. The Federal Deposit Insurance Corporation (FDIC) provides standard insurance coverage of $250,000 per insured bank for each account ownership category. As of September 30, 2026, the Company had not experienced losses on these accounts. As of September 30, 2026, the Company had deposited $545,039, with a financial institution in the United States. Of these balances $295,039 were not covered by deposit insurance. While management believes that the financial institution is of high credit quality, it also continually monitors its credit-worthiness.

 

 
12

Table of Contents

 

 

Ordinary Shares Subject to Possible Redemption

 

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026, 11,500,000 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s unaudited condensed balance sheets. As of September 30, 2026, the ordinary shares subject to possible redemption reflected in the unaudited condensed balance sheet are reconciled in the following table:

 

Gross proceeds

 

$115,000,000

 

Less:

 

 

 

 

Proceeds allocated to Public Right and Warrants

 

 

(14,048,000 )

Public Shares issuance costs

 

 

(2,804,726 )

Plus:

 

 

 

 

Remeasurement of carrying value to redemption value

 

 

16,852,726

 

Subsequent remeasurement of carrying value to redemption value

 

 

801,362

 

Ordinary shares subject to possible redemption, September 30, 2026

 

$115,801,362

 

 

Net Income (Loss) Per Ordinary Share

 

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of ordinary shares for purposes of computing net income (loss) per share: ordinary shares subject to possible redemption (“redeemable shares”) and non-redeemable ordinary shares, which include the Founder Shares, the Private Shares and the Representative Shares. In order to determine the net income (loss) attributable to the redeemable shares and the non-redeemable shares, the Company first considered the total net income (loss) allocable to both classes of shares, calculated as net income (loss) less any dividends paid. Any remeasurement of the carrying value of the redeemable shares to redemption value is considered to be a dividend paid to the public shareholders. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding of each class. Weighted average shares for periods prior to the Initial Public Offering were reduced for the effect of an aggregate of 375,000 ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. As of September 30, 2026 and 2025, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company, as the exercise of the Public Warrants and Private Warrants and the conversion of the Public Rights and Private Rights are contingent upon the occurrence of future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the periods presented.

 

The net income (loss) per share presented in the unaudited condensed statements of operations is based on the following:

 

 

 

For the Three Months Ended September 30, 2026

 

 

For the Nine Months Ended September 30, 2026

 

 

For the Three Months Ended September 30, 2025

 

 

For the Period from April 15, 2025 (Inception) through September 30, 2025

 

Net income (loss)

 

$613,858

 

 

$529,835

 

 

$(1,230)

 

$(1,230)

Initial accretion of carrying value to redemption value

 

 

(16,852,726)

 

 

(16,852,726)

 

 

—

 

 

 

—

 

Subsequent accretion of carrying value to redemption value

 

 

(801,362)

 

 

(801,362)

 

 

—

 

 

 

—

 

Net loss including accretion of carrying value to redemption value

 

$(17,040,230)

 

$(17,124,253)

 

$(1,230)

 

$(1,230)

 

 

 

Three Months Ended September 30, 2026 – Redeemable

 

 

Three Months Ended September 30, 2026 – Non-Redeemable

 

 

Nine Months Ended September 30, 2026 – Redeemable

 

 

Nine Months Ended September 30, 2026 – Non-Redeemable

 

Basic and diluted net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerators:

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of net loss including accretion of carrying value to redemption value

 

$(12,668,303)

 

$(4,371,927)

 

$(9,016,076)

 

$(8,108,177)

Accretion of carrying value to redemption value

 

 

17,654,088

 

 

 

—

 

 

 

17,654,088

 

 

 

—

 

Allocation of net income (loss)

 

$4,985,785

 

 

$(4,371,927)

 

$8,638,012

 

 

$(8,108,177)

Denominators:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

8,875,000

 

 

 

3,062,829

 

 

 

2,990,842

 

 

 

2,689,671

 

Basic and diluted net income (loss) per share

 

$0.56

 

 

$(1.43)

 

$2.89

 

 

$(3.01)

 

 
13

Table of Contents

 

 

For the three months ended September 30, 2025 and for the period from April 15, 2025 (inception) through September 30, 2025, there were no redeemable shares outstanding, and the net loss of $1,230 for each period was allocated entirely to the non-redeemable ordinary shares, based on 2,500,000 weighted average non-redeemable ordinary shares outstanding, resulting in basic and diluted net loss per non-redeemable ordinary share of $(0.00).

 

Recent Accounting Pronouncements

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, which amends the disclosure and presentation requirements of various Codification subtopics to align them with the SEC’s regulations. For entities subject to the SEC’s existing disclosure requirements, each amendment becomes effective on the date the SEC removes the related disclosure from Regulation S-X or Regulation S-K, and early adoption is not permitted. If the SEC has not removed the applicable requirement by June 30, 2027, the related amendment will not become effective. The Company is currently evaluating the impact of ASU 2023-06 on its unaudited condensed financial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures (Subtopic 220-40), which requires disclosure in the notes to the financial statements of specified information about certain costs and expenses presented on the face of the statement of operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on its unaudited condensed financial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies when a settlement of convertible debt is accounted for as an induced conversion. ASU 2024-04 is effective for annual periods beginning after December 15, 2025, with early adoption permitted. The Company adopted ASU 2024-04 effective January 1, 2026, and the adoption did not have a material impact on its unaudited condensed financial statements and related disclosures.

 

Except as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

Note 3 — INITIAL PUBLIC OFFERING

 

On July 22, 2026, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units”), which included 1,500,000 Units issued pursuant to the underwriters’ exercise in full of their over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share (a “Public Share”), one right to receive one-fourth (1/4) of one ordinary share (a “Public Right”), and one redeemable warrant (a “Public Warrant”). Each four Public Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination. Each whole Public Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share. Each Public Warrant will become exercisable on the later of (i) 30 days after the completion of an initial Business Combination and (ii) one year from the effective date of the registration statement related to the Initial Public Offering, and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade.

 

 
14

Table of Contents

 

Note 4 — PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 239,300 units (the “Private Units”) at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,393,000, in a private placement (the “Private Placement”). The Private Units are identical to the Units sold in the Initial Public Offering. Each Private Unit consists of one ordinary share (a “Private Share”), one right to receive one-fourth (1/4) of one ordinary share (a “Private Right”), and one redeemable warrant (a “Private Warrant”). Each four Private Rights entitle the holder thereof to receive one ordinary share upon the consummation of the Business Combination, and each whole Private Warrant entitles the holder thereof to purchase one ordinary share at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the Private Units and only whole warrants will trade.

 

The Sponsor has agreed to waive its redemption rights with respect to its Private Units (i) in connection with the consummation of a Business Combination, (ii) in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its initial Business Combination within 12 months after the closing of the Initial Public Offering, and (iii) if the Company fails to consummate a Business Combination within 12 months after the closing of the Initial Public Offering or if the Company liquidates prior to the expiration of the 12-month period. However, the Sponsor will be entitled to redemption rights with respect to any Public Shares held by it if the Company fails to consummate a Business Combination or liquidates within the 12-month period.

 

The Sponsor has agreed not to transfer, sell or assign the Private Units and the underlying securities until the consummation of the Company’s initial Business Combination.

 

Note 5 — RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On April 15, 2025, the Company issued 1 ordinary share of a par value of $1.00 each to McGrath Tonner Corporate Services Limited, which was transferred to the Sponsor on the same day without consideration. On April 15, 2025, the Company issued 49,999 ordinary shares of a par value of $1.00 each to the Sponsor. On November 25, 2025, the Sponsor acquired 172.5 ordinary shares of a par value of $1.00 each for a purchase price of $25,000 and surrendered 50,000 ordinary shares. On December 2, 2025, the Company effectuated a share subdivision of its issued and outstanding shares at a ratio of 1:10,000 (the “Share Subdivision”). Subsequent to the Share Subdivision, the 172.5 ordinary shares of a par value of $1.00 each held by the Sponsor became 1,725,000 ordinary shares of a par value of $0.0001 each.

 

On April 15, 2026, pursuant to an amendment to the securities purchase agreement, the Company issued 2,875,000 ordinary shares as founder shares (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In conjunction with the issuance, the Company repurchased and cancelled 1,725,000 previously issued ordinary shares held by the Sponsor for aggregate consideration of $25,000.

 

On July 16, 2026, the Sponsor transferred an aggregate of 14,000 Founder Shares to the Company’s officers and independent director nominees for aggregate consideration of $203.00, or approximately $0.0145 per share. The transfers consisted of 5,000 Founder Shares to the Chief Executive Officer for $72.50, 3,000 Founder Shares to the Chief Financial Officer for $43.50, and an aggregate of 6,000 Founder Shares to three independent director nominees for $87.00. The Sponsor, the above-mentioned officers, and the independent director nominees are collectively referred to as the “Founders.”

 

 
15

Table of Contents

 

 

The transfer of the 14,000 Founder Shares to the Company’s officers and independent director nominees was accounted for in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured based on the grant-date fair value of the awards. The total fair value of the 14,000 Founder Shares transferred was approximately $47,040, or $3.36 per share.

 

The Founder Shares included an aggregate of up to 375,000 Founder Shares that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full. As a result of the underwriters’ exercise in full of their over-allotment option in connection with the Initial Public Offering, no Founder Shares were forfeited.

 

The Founder Shares are designated as ordinary shares and are identical to the Private Placement Shares except for the following (a) Founder Shares must be voted in favor of any proposed Business Combination and cannot vote for amendments that would prevent public shareholders from converting or selling their shares in connection with a Business Combination, (b) Founder Shares cannot be converted into cash from the Trust Account in connection with a shareholder vote to approve the initial Business Combination or amend shareholders’ rights or pre-Business Combination activity. They do not participate in liquidating distributions if a Business Combination is not consummated. (c) Founder Shares cannot be transferred, assigned, or sold until the earlier of three months after the initial Business Combination or upon certain triggering events (e.g., liquidation, merger). If the share price exceeds $12.00 for 20 out of 30 trading days period commencing at least 90 days after a Business Combination, the lock-up is released.

 

Promissory Note — A Related Party

 

On April 7, 2026, the Company issued a promissory note to the Sponsor to evidence the loans previously provided to the Company by the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $500,000 to be used for a portion of the expenses of the Initial Public Offering. Prior to the closing of the Initial Public Offering, the Company had drawn down an aggregate of $469,300 under the promissory note.

 

The loan is non-interest bearing and unsecured and was due at the earlier of (1) December 31, 2026 or (2) the date on which the Company consummated the Initial Public Offering, unless accelerated upon the occurrence of an Event of Default. In connection with the closing of the Initial Public Offering on July 22, 2026, $433,000 of the outstanding balance under the promissory note was settled, and the remaining $36,300 was reclassified as other payable – related party. As of September 30, 2026 and December 31, 2025, $0 and $469,300, respectively, were outstanding under the promissory note. As of September 30, 2026, $36,300 was outstanding as other payable – related party.

 

Working Capital Loans

 

In addition, in order to meet the Company’s working capital needs following the consummation of the Initial Public Offering or to extend the Company’s life, the Company’s founders, officers and directors or their affiliates or designees may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. The loans (the “Working Capital Loans”) would be evidenced by promissory notes. The notes would either be repaid upon consummation of the Company’s initial Business Combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes may be converted upon consummation of the Company’s initial Business Combination into working capital units (the “Working Capital Units”) at a price of $10.00 per unit, in addition to the convertible notes in connection with potential extensions. The Company’s shareholders have approved the issuance of the Working Capital Units and underlying securities upon conversion of such notes, to the extent the holder wishes to so convert them at the time of the consummation of the Company’s initial Business Combination. If the Company does not complete a Business Combination, the Working Capital Loans will not be repaid. As of September 30, 2026 and December 31, 2025, the Company had no borrowings outstanding under the Working Capital Loans.

 

 
16

Table of Contents

 

 

Extension Loans

 

The Founders, officers and directors, or their affiliates or designees may loan (the “Extension Loans”) the Company funds in support of its potential extension to allow additional time for the Company to complete an initial business combination, which will be evidenced in extension convertible notes, or the “extension notes,” to be repaid in cash or, at the lender’s discretion, converted into units at a price of $10.00 per unit (the “Extension Units”) at the closing of our initial business combination. The Company’s shareholders have approved the issuance of the Extension Units and underlying securities upon conversion of such extension notes, to the extent the holder wishes to so convert them at the time of the consummation of our initial Business Combination. If the Company does not complete a Business Combination, the loans will not be repaid.

 

The Working Capital Units and Extension Units would be identical to the Private Units sold in the Private Placement. The terms of such loans by the Sponsor or its affiliates, if any, have not been determined and no written agreements exist with respect to such loans.

 

As of September 30, 2026 and December 31, 2025, the Company had no borrowings under the Working Capital Loans and Extension Loans.

 

Note 6 — COMMITMENTS AND CONTINGENCIES

 

Risks and Uncertainties

 

The Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Registration Rights

 

The holders of the Founder Shares, Private Units, Working Capital Units, Extension Units and any underlying securities are entitled to registration rights pursuant to a registration rights agreement entered into in connection with the Initial Public Offering, requiring the Company to register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the Company’s initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

In connection with the Initial Public Offering, the Company granted the underwriters a 45-day option to purchase up to an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. On July 22, 2026, the underwriters exercised the over-allotment option in full and purchased an additional 1,500,000 Units at $10.00 per Unit, generating additional gross proceeds of $15,000,000.

 

The Company paid an underwriting discount of 1.0% of the gross proceeds of the Initial Public Offering, or $1,150,000, to the underwriters at the closing of the Initial Public Offering, in addition to the issuance of the Representative Shares. In addition, an underwriting discount of 1.0% of the gross proceeds of the Initial Public Offering, or $1,150,000, will be paid in cash as the deferred underwriting commission upon the consummation of the Business Combination. As of September 30, 2026, deferred underwriting commission payable of $1,150,000 was recorded on the unaudited condensed balance sheet.

 

 
17

Table of Contents

 

Note 7 — SHAREHOLDER’S EQUITY

 

Preferred Shares

 

The Company is authorized to issue 10,000,000 preferred shares, with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Ordinary Shares

 

On April 15, 2025, the Company issued 1 ordinary share of a par value of $1.00 each to McGrath Tonner Corporate Services Limited, which was transferred to the Sponsor on the same day without consideration. On the same day, the Company issued 49,999 ordinary shares of a par value of $1.00 each to the Sponsor.

 

On November 25, 2025, the Company issued 172.5 ordinary shares of a par value of $1.00 each to the Sponsor for a purchase price of $25,000, and in conjunction with the issuance, the Sponsor surrendered the previously issued 50,000 ordinary shares for no consideration.

 

On December 2, 2025, the Company effectuated the Share Subdivision. Subsequent to the Share Subdivision, the 172.5 ordinary shares of a par value of $1.00 each held by the Sponsor became 1,725,000 ordinary shares of a par value of $0.0001 each.

 

On April 15, 2026, the Company issued 2,875,000 Founder Shares to the Sponsor for an aggregate purchase price of $25,000. In conjunction with the issuance, the Company repurchased and cancelled from the Sponsor 1,725,000 previously issued ordinary shares for aggregate consideration of $25,000.

 

On July 16, 2026, the Sponsor transferred 5,000 Founder Shares to the Chief Executive Officer, 3,000 Founder Shares to the Chief Financial Officer, and 6,000 Founder Shares to independent director nominees, for an aggregate of 14,000 Founder Shares.

 

The Founder Shares included an aggregate of up to 375,000 Founder Shares that were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full. As a result of the underwriters’ exercise in full of their over-allotment option in connection with the Initial Public Offering, no Founder Shares were forfeited.

 

The Company issued to the underwriter 115,000 ordinary shares (the “Representative Shares”) in connection with the consummation of the Initial Public Offering, including the underwriters’ exercise in full of the over-allotment option. The underwriter has agreed not to transfer, assign or sell any such shares until the completion of the Company’s initial Business Combination. In addition, the underwriter has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of the Company’s initial Business Combination or a shareholder vote to approve an amendment to the Company’s governing documents to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination; (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete its initial Business Combination within the prescribed time period; and (iii) to vote for any proposal in connection with a Business Combination or proposal to amend the then-existing memorandum and articles of association, as amended, to modify the amount of time or substance the Company has to consummate an initial Business Combination.

 

The Representative Shares are subject to a lock-up for a period of 180 days immediately following the commencement of sales of the Initial Public Offering pursuant to FINRA Rule 5110(e)(1). Pursuant to this FINRA lock-up, these securities cannot be sold, transferred, assigned, pledged or hypothecated or be subject to any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days from the commencement of sales of the Initial Public Offering, except as permitted under FINRA Rule 5110(e)(2), including transfers to any underwriter and selected dealer participating in the offering and their officers or partners, registered persons or affiliates.

 

Shareholders of ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable share exchange rules, the affirmative vote of a majority of the Company’s issued and outstanding ordinary shares that are voted at a shareholder meeting (in person or by proxy) is required to approve any such matter voted on by the Company’s shareholders. Approval of certain actions will require a special resolution under Cayman Islands law and pursuant to the Company’s amended and restated memorandum and articles of association; such actions include amending the Company’s amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company.

 

 
18

Table of Contents

 

 

The Company may by ordinary resolution appoint any person to be a director or may by ordinary resolution remove any director. There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voted for the election of directors can elect all of the directors. The directors of the Company may appoint any person to be a director, either to fill a vacancy or as an additional director, provided that the appointment does not cause the number of directors to exceed any number fixed by or in accordance with the Company's amended and restated memorandum and articles of association as the maximum number of directors. The Company’s shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefore.

 

As of September 30, 2026 and December 31, 2025, the Company had 3,229,300 and 2,875,000 ordinary shares issued and outstanding, respectively (excluding 11,500,000 and nil shares subject to possible redemption, respectively).

 

Rights

 

Each holder of a Right will automatically receive one-fourth (1/4) of one ordinary share upon consummation of the Company’s initial Business Combination, even if the holder of such Right redeemed all ordinary shares held by it in connection with the initial Business Combination or an amendment to the Company’s amended and restated memorandum and articles of association with respect to the Company’s pre-Business Combination activities. In the event the Company is not the surviving company upon completion of its initial Business Combination, each Right will automatically be converted to receive the kind and amount of securities or property of the surviving entity that one-fourth of one ordinary share underlying each Right is entitled to receive in the Business Combination, subject to any dissenters’ rights under applicable law. No additional consideration will be required to be paid by a holder of Rights in order to receive the ordinary shares issuable upon conversion of the Rights upon consummation of an initial Business Combination. The shares issuable upon the conversion of the Rights will be freely tradable (except to the extent held by the Company’s affiliates). If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of Rights to receive the same per-share consideration that the holders of the ordinary shares will receive in the transaction on an as-converted basis.

 

The Company will not issue fractional shares in connection with the conversion of Rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Companies Act and any other applicable law. As a result, holders must hold Rights in multiples of four in order to receive shares for all of their Rights upon closing of a Business Combination. If the Company is unable to complete an initial Business Combination within the required time period and liquidates the funds held in the Trust Account, holders of Rights will not receive any of such funds with respect to their Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Rights, and the Rights will expire worthless. Additionally, in no event will the Company be required to net cash settle the Rights. Accordingly, the Rights may expire worthless.

 

The Company shall reserve such amount of its profits or share premium as necessary to pay up the par value of each share issuable in respect of the Rights.

 

As of September 30, 2026, there were 11,500,000 Public Rights and 239,300 Private Rights outstanding.

 

Warrant

 

Each whole warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment pursuant to the terms of the warrant agreement. The warrants become exercisable on the later of (i) 30 days after the completion of the Company’s initial Business Combination and (ii) one year from the effective date of the registration statement related to the Company’s Initial Public Offering, and expire five years after the completion of the initial Business Combination, unless earlier redeemed or liquidated.

 

 
19

Table of Contents

 

 

The Company is not obligated to deliver ordinary shares pursuant to the exercise of a warrant unless a registration statement under the Securities Act covering the issuance of the ordinary shares underlying the warrants is then effective and a current prospectus relating thereto is available, subject to the Company’s obligations to use its best efforts to maintain the effectiveness of such registration statement. If a registration statement covering the ordinary shares issuable upon exercise of the warrants is not effective within 60 business days following the consummation of the initial Business Combination, holders may exercise the warrants on a cashless basis pursuant to an available exemption under the Securities Act.

 

The exercise price and redemption trigger price are subject to adjustment in certain circumstances, including if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at a price below $9.20 per share and specified conditions are met.

 

The Company may redeem the outstanding warrants, in whole and not in part, at a price of $0.01 per warrant upon not less than 30 days’ prior written notice, if the closing price of the Company’s ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading-day period ending three business days before the Company sends the notice of redemption, provided that an effective registration statement covering the ordinary shares issuable upon exercise of the warrants is available throughout the redemption period.

 

If the Company elects to redeem the warrants, the Company may require holders to exercise their warrants on a cashless basis. In addition, if the ordinary shares are not listed on a national securities exchange and do not qualify as “covered securities” under applicable securities laws, the Company may require holders to exercise the warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act.

 

As of September 30, 2026, there were 11,500,000 Public Warrants and 239,300 Private Warrants outstanding.

 

Note 8 — FAIR VALUE MEASUREMENTS

 

The Company follows the fair value hierarchy described in Note 2, “Fair Value of Financial Instruments Measurements.” Investments held in the Trust Account are measured at fair value on a recurring basis and are classified within Level 1 of the hierarchy (see Note 2).

 

Non-Recurring Fair Value Measurements

The fair values of the Representative Shares, the Founder Shares transferred to the Company’s officers and independent director nominees, the Public Warrants and the Public Rights were measured on a non-recurring basis as of their issuance or transfer dates using Level 3 inputs, as described below.

Representative Shares

 

The fair value of the Representative Shares was approximately $388,000, or $3.37 per Representative Share, at the issuance date. In connection with the initial public offering, the Company agreed to issue 115,000 ordinary shares to the representative of the underwriters and/or its designees. The fair value of the Representative Shares was determined using a Black-Scholes model, adjusted for a discount for lack of marketability and the estimated probability of successfully completing an initial Business Combination. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Representative Shares:

 

 

 

July 22,

2026

 

Underlying stock price

 

$8.79

 

Exercise price

 

$0.00

 

Volatility

 

 

15.00%

Remaining term (in years)

 

 

1

 

Risk-free rate

 

 

4.11%

Dividend yield

 

 

0.00%

Discount of lack of marketability

 

 

4.1%

Probability of completion of Business Combination

 

 

40.0%

 

 
20

Table of Contents

 

 

Founder Shares

 

The Company established the fair value of the 14,000 Founder Shares transferred to the Company’s officers and independent director nominees using a valuation prepared by a third-party valuation firm using a Black-Scholes model. The valuation incorporated an estimated probability of successfully completing the initial public offering. The fair value of the Founder Shares was approximately $47,180 in the aggregate, or $3.37 per Founder Share, as of July 22, 2026. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Founder Shares:

 

 

 

July 22,

2026

 

Underlying stock price

 

$8.79

 

Exercise price

 

$0.00

 

Volatility

 

 

15.00%

Remaining term (in years)

 

 

1

 

Risk-free rate

 

 

4.16%

Dividend yield

 

 

0.00%

Discount of lack of marketability

 

 

4.3%

Probability of completion of Business Combination

 

 

40.0%

 

Public Warrants

 

The fair value of the Public Warrants was approximately $3,940,000, or $0.34 per Public Warrant, at the issuance date. The fair value of the Public Warrants was determined using a Black-Scholes model. The Public Warrants have been classified within shareholders’ deficit and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Warrants:

 

 

 

July 22,

2026

 

Underlying stock price

 

$8.79

 

Exercise price

 

$11.50

 

Volatility

 

 

10.00%

Remaining term (in years)

 

 

6.01

 

Risk-free rate

 

 

4.47%

Dividend yield

 

 

0.00%

Probability of completion of Business Combination

 

 

40.0%

 

 
21

Table of Contents

 

 

Public Rights

 

The fair value of the Public Rights was approximately $10,108,000, or $0.88 per Public Right, at the issuance date. The fair value of the Public Rights was determined using a Black-Scholes model based on the contractual terms of the Public Rights, pursuant to which each Public Right entitles the holder to receive one-fourth (1/4) of one ordinary share upon consummation of the Company’s initial Business Combination. The Public Rights have been classified within shareholders’ deficit and will not require subsequent remeasurement after issuance. The following table presents the quantitative information regarding the significant assumptions used in the Level 3 valuation of the Public Rights:

 

 

 

July 22,

2026

 

Underlying stock price

 

$2.20

 

Exercise price

 

$0.00

 

Volatility

 

 

15.00%

Remaining term (in years)

 

 

1.00

 

Risk-free rate

 

 

4.11%

Dividend yield

 

 

0.00%

Probability of completion of Business Combination

 

 

40.0%

 

Note 9 — SEGMENT INFORMATION

 

FASB ASC Topic 280, Segment Reporting, establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

 

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.

 

The CODM assesses performance for the single segment and decides how to allocate resources. The measure of segment assets is reported on the unaudited condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews the following significant components of total assets:

 

 

 

September 30, 2026

 

 

December 31, 2025

 

Cash

 

$545,039

 

 

$346,015

 

Prepaid expenses

 

$95,742

 

 

$43,000

 

Investments held in Trust Account

 

$115,801,362

 

 

$—

 

 

The CODM reviews the position of total assets available with the company to assess if the Company has sufficient resources available to discharge its liabilities. The CODM is provided with details of cash and liquid resources available with the Company.

 

The CODM assesses performance for the single segment based on net income or loss, which is reported on the unaudited condensed statements of operations as net income (loss). The Company’s significant segment expenses are formation and operating costs, and the CODM also reviews income earned on investments held in the Trust Account. The following significant segment items are regularly provided to the CODM:

 

 

 

For the Three Months Ended September 30, 2026

 

 

For the Three Months Ended September 30, 2025

 

 

For the Nine Months Ended September 30, 2026

 

 

For the Period from April 15, 2025 (Inception) through September 30, 2025

 

Formation and operating costs

 

$187,504

 

 

$1,230

 

 

$271,527

 

 

$1,230

 

Income earned on investments held in Trust Account

 

$801,362

 

 

$—

 

 

$801,362

 

 

$—

 

Net income (loss)

 

$613,858

 

 

$(1,230)

 

$529,835

 

 

$(1,230)

 

Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the required period. All other segment items included in net income (loss) are reported on the unaudited condensed statements of operations and described within their respective disclosures. As of September 30, 2026 and December 31, 2025, the Company had total assets of $116,442,143 and $489,015, respectively.

 

Note 10 — SUBSEQUENT EVENTS

 

The Company’s management reviewed all material events that have occurred after the balance sheet date through the date the unaudited condensed financial statements were issued. Based on the review, management did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

 
22

Table of Contents

  

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings. References to the “Company”, “us,” “our,” or “we” refer to Southern Cross Acquisition I Corp. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes herein.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company with limited liability on April 15, 2025, under our former name RTNVM Acquisition Corp., which was changed to Southern Cross Acquisition I Corp. on August 4, 2025, for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. To date, we have not selected any potential target business nor initiated any substantive discussions, directly or indirectly, with any such prospect. We have selected December 31 as our fiscal year end.

 

We presently have no revenue, have had losses since inception from incurring formation and operating costs and have had no operations other than identifying and evaluating suitable acquisition transaction candidates. Prior to the consummation of the IPO (as defined below), our liquidity needs were satisfied through advances from our Sponsor (as defined below) pursuant to an unsecured promissory note. Following the consummation of the IPO and the Private Placement (as defined below), we have relied upon the working capital held outside the Trust Account (as defined below) to fund our operations, as well as any funds loaned by the Sponsor, our officers, directors or their affiliates. We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial business combination will be successful.

 

On July 22, 2026, we consummated the initial public offering (the “IPO”) of 11,500,000 units (the “Units”), which included 1,500,000 Units issued pursuant to the underwriters’ exercise in full of their over-allotment option. Each Unit consists of one ordinary share, $0.0001 par value per share (each, an “Ordinary Share”), one right (each, a “Right”) entitling the holder thereof to receive one-fourth (1/4) of one Ordinary Share upon the consummation of the Company’s initial business combination, and one redeemable warrant (each, a “Warrant”), each whole Warrant entitling the holder thereof to purchase one Ordinary Share at an exercise price of $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $115,000,000. D. Boral Capital LLC acted as the representative of the underwriters of the IPO (the “Representative”).

 

Simultaneously with the consummation of the IPO, we consummated the private placement of 239,300 units (the “Private Units”) to our Sponsor, Southern Cross Acquisition I Sponsor Corp. (the “Sponsor”), at a price of $10.00 per Private Unit, generating gross proceeds of $2,393,000 (the “Private Placement”). The Private Units are identical to the Units sold in the IPO.

 

A total of $115,000,000 ($10.00 per Unit) from the net proceeds of the IPO and the sale of the Private Units was placed in a trust account (the “Trust Account”) established for the benefit of our public shareholders and the underwriters of the IPO with Continental Stock Transfer & Trust Company acting as trustee. The remaining $645,899 of proceeds was held outside the Trust Account.

 

We also issued to the Representative 115,000 Ordinary Shares as part of the underwriting compensation (the “Representative Shares”), which were issued upon the closing of the IPO. We paid the Representative an underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,150,000, at the closing of the IPO, and an additional 1.0% of the gross proceeds of the IPO, or $1,150,000, will be payable in cash as a deferred underwriting commission upon the consummation of our initial business combination. The Representative Shares are identical to the Ordinary Shares included in the Units, with certain exceptions.

 

 
23

Table of Contents

 

Results of Operations and Known Trends or Future Events

 

We have neither engaged in any operations nor generated any revenues to date. Our activities from April 15, 2025 (inception) through September 30, 2026 were related to the Company’s formation, the IPO and, following the IPO, the search for a target business. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. Following the IPO, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for expenses associated with the search for target opportunities. 

 

For the three months ended September 30, 2026, we had net income of $613,858, which consisted of income earned on investments held in the Trust Account of $801,362, offset by formation and operating costs of $187,504. For the nine months ended September 30, 2026, we had net income of $529,835, which consisted of income earned on investments held in the Trust Account of $801,362, offset by formation and operating costs of $271,527. For the three months ended September 30, 2025 and for the period from April 15, 2025 (inception) through September 30, 2025, we had a net loss of $1,230, which consisted of formation and operating costs.

  

Liquidity and Capital Resources 

 

As of September 30, 2026, we had cash of $545,039 available for working capital needs. We intend to use substantially all of the net proceeds of the IPO, including the funds held in the Trust Account, to acquire a target business or businesses and to pay our expenses relating thereto. To the extent that our share capital is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the Trust Account as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.

 

Over the next 12 months (assuming a business combination is not consummated prior thereto), we will be using the funds held outside of the Trust Account for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the business combination.

 

If our estimates of the costs of undertaking in-depth due diligence and negotiating our initial business combination is less than the actual amount necessary to do so, or the amount of interest available to us from the Trust Account is less than we expect as a result of the current interest rate environment, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial business combination. Following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

 

As of September 30, 2026, we had cash of $545,039 and working capital of $520,921. On April 7, 2026, we issued an unsecured promissory note to the Sponsor to evidence the loans previously provided to us by the Sponsor, pursuant to which the Sponsor agreed to loan us up to $500,000 to fund a portion of the expenses related to the IPO, of which an aggregate of $469,300 had been drawn down prior to the closing of the IPO. In connection with the closing of the IPO on July 22, 2026, $433,000 of the outstanding balance under the promissory note was settled and the remaining $36,300 was reclassified as other payable – related party. As of September 30, 2026, there was no outstanding balance under the promissory note. We have incurred and expect to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a business combination. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern. Our management’s plan in addressing this uncertainty is through the funds held outside the Trust Account, together with working capital loans from our founders, officers, directors or their affiliates or designees, if necessary. In addition, if we are unable to complete a business combination within 12 months from the closing of the IPO, or by July 22, 2027 (unless such period is extended pursuant to our amended and restated memorandum and articles of association) (the “Combination Period”), our board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of us. There is no assurance that our plans to consummate a business combination will be successful within the Combination Period. As a result, management has determined that such additional conditions also raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

For the nine months ended September 30, 2026, net cash used in operating activities was $290,649, which consisted of net income of $529,835, adjusted for income earned on investments held in the Trust Account of $801,362 and share-based compensation of $47,180, and changes in operating assets and liabilities that used $66,302 of cash. For the period from April 15, 2025 (inception) through September 30, 2025, net cash used in operating activities was $44,230, which consisted of a net loss of $1,230 and changes in operating assets and liabilities that used $43,000 of cash.

 

For the nine months ended September 30, 2026, net cash used in investing activities was $115,000,000, which consisted of the investment of cash in the Trust Account. There were no investing activities for the period from April 15, 2025 (inception) through September 30, 2025.

 

For the nine months ended September 30, 2026, net cash provided by financing activities was $115,489,673, which consisted of proceeds from the sale of Units, net of underwriting discounts paid, of $113,850,000 and proceeds from the sale of Private Units of $2,393,000, offset by the repayment of the promissory note – related party of $433,000 and the payment of offering costs of $320,327. For the period from April 15, 2025 (inception) through September 30, 2025, net cash provided by financing activities was $148,000, which consisted of proceeds from the promissory note – related party of $173,000 and proceeds from the issuance of ordinary shares to the Sponsor of $25,000, offset by the payment of offering costs of $50,000.

 

As of September 30, 2026, we had investments held in the Trust Account of $115,801,362, including $801,362 of income earned on investments held in the Trust Account.

 

 
24

Table of Contents

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities that would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

As of September 30, 2026, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the deferred underwriting commission of $1,150,000 payable to the Representative upon the consummation of our initial business combination.

 

The Ordinary Shares initially issued to the Sponsor prior to the consummation of the IPO (the “Founder Shares”), Ordinary Shares included in the Private Units, and any Ordinary Shares that may be issued upon conversion of working capital loans or extension loans (and any underlying securities) will be entitled to registration rights pursuant to a registration rights agreement entered into in connection with the IPO, requiring us to register such securities for resale. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Critical Accounting Estimates

 

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. We have not identified any critical accounting estimates.

 

Recent Accounting Pronouncements

 

In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-06, Disclosure Improvements — Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, which amends the disclosure or presentation requirements of a variety of codification subtopics. The amendments represent changes to clarify or improve disclosure and presentation requirements of those subtopics and align the requirements in the Codification with the SEC’s regulations. For entities subject to existing SEC disclosure requirements, the effective date aligns with the date on which the SEC removes the related disclosure from Regulation S-X or Regulation S-K, and early adoption is not permitted. If the SEC has not removed the applicable requirements by June 30, 2027, the related amendments will not become effective. The Company is currently evaluating the impact of the update on its financial statements and related disclosures.

 

On November 4, 2024, the FASB issued ASU No. 2024-03, Expense Disaggregation Disclosures (“ASU 2024-03”). ASU 2024-03 amends ASC 220, Comprehensive Income, to expand income statement expense disclosures and to require disclosure in the notes to the financial statements of specified information about certain costs and expenses. ASU 2024-03 is required to be adopted for fiscal years commencing after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of adopting the standard on its financial statements.

 

In November 2024, the FASB issued ASU 2024-04, Debt — Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the accounting guidance for induced conversions of convertible debt. The amendments clarify that, to account for a settlement as an induced conversion, an inducement offer must provide at least the consideration (in form and amount) issuable under the original conversion terms, even for instruments with cash conversion features, and that the guidance applies to instruments not currently convertible provided they had a substantive conversion feature at issuance and at the time of the inducement offer. The amendments are effective for annual periods beginning after December 15, 2025, with early adoption permitted for entities that have adopted ASU 2020-06. The Company is currently evaluating the impact of the update on its financial statements and related disclosures.

 

Except as mentioned above, the Management does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the on our financial statements.

 

 
25

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES 

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer) (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2026, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our chief executive officer and chief financial officer concluded that, have concluded that during the period covered by this report, our disclosure controls and procedures were not effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

This quarterly report on Form 10-Q (the “Quarterly Report”) does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

 

Changes in Internal Control Over Financial Reporting

 

During the period covered by this Quarterly Report on Form 10-Q, there has been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter covered by this report that has materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
26

Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best of our knowledge, against us. 

 

ITEM 1A. RISK FACTORS.

 

As a smaller reporting company, we are not required to include risk factors in this Report. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Prospectus. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Prospectus.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES.

 

Unregistered Sales of Equity Securities

 

Substantially concurrently with the closing of the IPO, the Company completed the private sale of 239,300 Private Placement Units to the Company’s sponsor, Southern Cross Acquisition I Sponsor Corp. (the “Sponsor”), a Cayman Islands exempted company, for an aggregate purchase price of $2,393,000. The Private Placement Units are identical to the Units issued in the IPO, subject to limited exceptions as further described in the registration statement filed in connection with the IPO.

 

The above sales were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No commissions were paid in connection with such sales.

 

Use of Proceeds

 

On July 22, 2026, the Company consummated its initial public offering of 11,500,000 Units, including full exercise of the underwriters’ option to purchase an additional 1,500,000 units to cover over-allotments. Each Unit consists of one ordinary share, one redeemable warrant, and one right to receive one-fourth of one ordinary share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $115,000,000.

 

Substantially concurrently with the closing of the initial public offering, the Company completed the private sale of 239,300 Private Placement Units to the Sponsor for an aggregate purchase price of $2,393,000. The Private Placement Units are identical to the Units issued in the IPO, subject to limited exceptions as further described in the registration statement filed in connection with the IPO.

 

A total of $115,000,000.00, from the proceeds received from the consummation of the initial public offering and simultaneous private placement (net of transaction expenses and working capital) were placed in the Company’s trust account established for the benefit of the Company’s public shareholders and the underwriters of the IPO with Continental Stock Transfer & Trust Company, acting as trustee. We incurred transaction costs of $3,204,997 in connection with the IPO, consisting of $1,150,000 of underwriting commissions paid in cash at the closing of the IPO, $1,150,000 of deferred underwriting commissions, $387,550 of the fair value of the Representative Shares and $517,447 of other offering costs.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

 
27

Table of Contents

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit No.

 

Description

31.1*

 

Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

 

Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1**

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*

 

Inline XBRL Instance Document

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

 

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

*

Filed herewith

**

Furnished.

 

 
28

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Southern Cross Acquisition I Corp.

 

 

 

 

 

Date: November 17, 2026

By:

/s/ Ally Tong Zhang

 

 

 

Ally Tong Zhang

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

Date: November 17, 2026

By:

/s/ Siu Wai Lam

 

 

 

Siu Wai Lam

 

 

 

Chief Financial Officer

(Principal Financial Officer)

 

 

 
29

 

Keep reading